Intracellular hypoxia measured by 18Ffluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptorpositive breast cancer
Bioportfolio,
Hypoxia is a key driver of cancer progression. We evaluated the prognostic impact of 18F-fluoromisonidazole (FMISO) prior to…